COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,755 Articles (22,502 medRxiv, 8,253 bioRxiv)

Most recent first Previous |  Page 1509: Articles 15081-15090  | Next

LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
Temesgen, Z., Burger, C. D., Baker, J., Polk, C., Libertin, C., Kelley, C., Marconi, V. C., Orenstein, R., Durrant, C., Chappell, D., Ahmed, O., Chappell, G., Badley, A.
10.1101/2021.05.01.21256470 — Posted: 2021-05-05
Prevalence of anxiety, depression, and stress among teachers during the COVID-19 pandemic: Systematic review
Silva, D. F. d. O., Cobucci, R. N. O., Lima, S. C. V. C., Andrade, F. B. d.
10.1101/2021.05.01.21256442 — Posted: 2021-05-05
Effect of commuting on the risk of COVID-19 and COVID-19-induced anxiety
Ando, H., Ikegami, K., Nagata, T., Tateishi, S., Eguchi, H., Tsuji, M., Matsuda, S., Fujino, Y., Ogami, A., the CORoNaWork project
10.1101/2021.05.01.21256090 — Posted: 2021-05-05
Population Vaccine Effectiveness and its Implication for Control of the Spread of COVID-19 in the US
Hu, Z., Ge, Q., Luo, L., Xu, T., Zhang, K., Lu, H. H., Lin, W., Boerwinkle, E., Jin, L., Xiong, M.
10.1101/2021.04.30.21256228 — Posted: 2021-05-05
Immunolocalization studies of vimentin and ACE2 on the surface of cells exposed to SARS-CoV-2 Spike proteins
Lalioti, V., Gonzalez-Sanz, S., Lois-Bermejo, I., Gonzalez-Jimenez, P., Viedma-Poyatos, A., Merino, A., Pajares, M. A., Perez-Sala, D.
10.1101/2021.05.04.442648 — Posted: 2021-05-04
Disordered eating and self-harm as risk factors for poorer mental health during the COVID-19 pandemic: A population-based cohort study
Warne, N., Heron, J., Mars, B., Kwong, A. S. F., Solmi, F., Pearson, R., Moran, P., Bould, H.
10.1101/2021.04.30.21256377 — Posted: 2021-05-04
Does the elevated thrombosis risk of males relative to females help account for the excess male mortality observed in Covid-19? An observational study
Cohen, K. R., Anderson, D., Ren, S., Cook, D. J.
10.1101/2021.05.04.21256001 — Posted: 2021-05-04
Modeling and Predicting Antibody Durability for mRNA-1273 Vaccine for SARS-CoV-2 Variants
Luo, G., Hu, Z., Letterio, J.
10.1101/2021.05.04.21256537 — Posted: 2021-05-04
Environmental Screening for Surface SARS-CoV-2 Contamination in Urban High-Touch Areas
Roppolo Brazell, L., Stetz, S., Hipp, A., Taylor, S., Stark, N., Jensen, K., Juel, M. A. I., Deegan, P., Munir, M., Schlueter, J., Weller, J. W., Gibas, C. J.
10.1101/2021.05.04.21256107 — Posted: 2021-05-04
Distinct patterns of blood cytokines beyond a cytokine storm predict mortality in COVID-19
Herr, C., Mang, S., Mozafari, B., Guenther, K., Speer, T., Seibert, M., Srikakulam, S. K., Beisswenger, C., Ritzmann, F., Keller, A., Mueller, R., Smola, S., Eisinger, D., Zemlin, M., Danziger, G., Volk, T., Hoersch, S., Krawczyk, M., Lammert, F., Adams, T., Wagenpfeil, G., Kindermann, M., Marcu, C., Ataya, Z. W. D., Mittag, M., Schwarzkopf, K., Custodis, F., Grandt, D., Schaefer, H., Eltges, K., Lepper, P., Bals, R.
10.1101/2021.05.04.21256497 — Posted: 2021-05-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).